SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jul 14, 2026

BCAX

Bicara Therapeutics Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 3 insiders, $0.3M total
Actionable Insight • Neutral

This cluster is routine and non-material. The CEO's sales are clearly tied to option exercise and tax withholding, not a bearish view. No trading action warranted; monitor for any material corporate events (e.g., pipeline data, earnings) that could drive the stock independently.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$28.12
T+0 close · Jul 14, 2026 · via day close
Latest settled
−38.61%
T+60 · $17.26
Vs SPY
−41.14%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 15 $28.12entry
  2. T+1 · 4mo ago −1.83%α −1.29% · $27.60
  3. T+5 · 4mo ago −0.55%α +0.43% · $27.96
  4. T+20 · 3mo ago −12.40%α −14.74% · $24.63
  5. T+60 · 6w ago −38.61%α −41.14% · $17.26
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three BCAX insiders, including the CEO and CFO, sold a total of ~$324K in shares over a 7-day window. The CEO's sales followed option exercises at a fraction of the market price, a routine pattern for tax planning. The total value is only ~0.02% of the $1.8B market cap, making this cluster economically trivial and non-informative.

Key Financial Metrics

Direction
selling
Total Value
$324.0K
Insiders
3

Key Facts

  • CEO Claire Mazumdar sold 10,000 shares for ~$284K after exercising options at $3.79 and $0.
  • CFO Ivan Hyep sold 830 shares for ~$25K.
  • President/COO Ryan Cohlhepp sold 536 shares for ~$16K.
  • Total cluster value of ~$324K represents ~0.02% of BCAX's $1.8B market cap.
  • All sales were open-market; no cluster buys were present.

Financial Impact

Total insider sales of ~$324K, or ~0.02% of market cap, negligible economic impact.

dilution

Risk Factors

  • Insider sales are small and routine, no elevated risk of adverse news.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BCAX-1784103345688

Track record

26 reports on BCAX

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +5.65% at T+20 after the Apr 15, 2026 report. 1 of 3 went positive at some point.

Filters
  1. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $9.98 Now $9.75 −2.30% settles Dec 8
  2. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $8.89 Now $9.75 +9.67% settles Dec 3
  3. Nov 4, 202612d ago Press Release Neutral 2/10 Entry $8.89 Now $9.75 +9.67% settles Dec 3
  4. Oct 7, 20265w ago SC 13G/A Neutral 3/10 Entry $16.42 to $8.89 Now $9.75 −40.62% ▼ −45.86% −44.52% vs SPY
  5. Oct 5, 20266w ago Press Release Neutral 2/10 Entry $17.29 to $9.13 Now $9.75 −43.61% ▼ −47.19% −44.73% vs SPY
  6. Sep 22, 20267w ago Institutional Cluster Bullish 4/10 Entry $22.78 to $18.35 Now $9.75 −57.20% ▼ −19.45% −18.89% vs SPY
  7. Aug 25, 202611w ago 8-K Neutral 2/10 Entry $24.73 to $19.78 Now $9.75 −60.57% ▼ −20.02% −20.24% vs SPY
  8. Aug 14, 202613w ago Press Release Neutral 2/10 Entry $24.28 to $23.20 Now $9.75 −59.84% ▼ −4.45% −2.46% vs SPY
  9. Aug 12, 202613w ago Insider Cluster Neutral Not scored Entry $23.63 to $22.81 Now $9.75 −58.74% ▼ −3.47% −1.72% vs SPY
  10. Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $23.63 to $22.81 Now $9.75 −58.74% ▼ −3.47% −1.72% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (10h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 15, 2026